Vernon, Anthony C.
King's College London · MRC Centre for Neurodevelopmental Disorders
7 papers on CoChatORCID 0000-0001-7305-1069
Most cited papers
- Verified
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
Onwordi, E. C., Halff, E. F., Whitehurst, T., Mansur, A., Cotel, M.-C., Wells, L., Creeney, H., Bonsall, D., Rogdaki, M., Shatalina, E., et al. (2020) · Nature Communications
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 243
- Verified
Schizophrenia and influenza at the centenary of the 1918–1919 Spanish Influenza Pandemic: mechanisms of psychosis risk
Kępińska, A. P., Iyegbe, C. O., Vernon, A. C., Yolken, R., Murray, R. M., & Pollak, T. A. (2020) · Frontiers in Psychiatry
Tryptophan and brain disordersSchizophrenia research and treatment
Cited by 193
- Verified
Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation
Vernon, A. C., Natesan, S., Modo, M., & Kapur, S. (2011) · Biological Psychiatry
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 173
- Verified
Evolution of structural abnormalities in the rat brain following in utero exposure to maternal immune activation: a longitudinal in vivo MRI study
Crum, W. R., Sawiak, S. J., Chege, W., Cooper, J. D., Williams, S. C. R., & Vernon, A. C. (2017) · Brain Behavior and Immunity
Tryptophan and brain disordersStress Responses and Cortisol
Cited by 76
- Verified
The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study
Onwordi, E. C., Whitehurst, T., Mansur, A., Statton, B., Berry, A., Quinlan, M., O’Regan, D. P., Rogdaki, M., Marques, T. R., Rabiner, E. A., et al. (2021) · Translational Psychiatry
Schizophrenia research and treatmentNeuroscience and Neuropharmacology Research
Cited by 55
- Verified
Heterozygous expression of the Alzheimer’s disease-protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapses
Solomon, S., Sampathkumar, N. K., Carre, I., Mondal, M., Chennell, G., Vernon, A. C., Ruepp, M.-D., & Mitchell, J. C. (2022) · Cellular and Molecular Life Sciences
Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments
Cited by 23
- Verified
Effects of chronic exposure to haloperidol, olanzapine or lithium on SV2A and NLGN synaptic puncta in the rat frontal cortex
Halff, E. F., Cotel, M.-C., Natesan, S., McQuade, R., Ottley, C. J., Srivastava, D. P., Howes, O. D., & Vernon, A. C. (2021) · Behavioural Brain Research
Schizophrenia research and treatmentNeuroscience and Neuropharmacology Research
Cited by 18
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free